With the ever-increasing interest being taken in toxoplasmosis more and more requests are reaching laboratories for help in its diagnosis.
Prominent among the diagnostic tests employed is the cytoplasm-modifying-antibody (dye) test introduced by Sabin and Feldman (1948) . Briefly, this consists in mixing varying dilutions of the patient's serum with peritoneal exudate rich in Toxoplasma from an inoculated mouse, incubating the mixture, and then adding methylene blue. If the patient's serum contains antibody the Toxoplasma will not take up the dye. We have been using this test since 1949. It has been our aim to control or correct variable factors as far as possible so that the results obtained from day to day may be consistent within our own laboratory. Our immediate hope in writing this paper is that we may help others to overcome difficulties that we have encountered, and our ultimate hope that from studies such as ours there may evolve a universally accepted technique that will produce consistent results between laboratories.
With these objects in view, we propose to discuss the reagents used in the test and to describe modifications we have thought desirable.
Materials and Methods
Patient's Serum.-When we first started using the Sabin-Feldman test we used freeze-dried specimens in order to preserve the labile, complement-like " accessory factor" present in the patient's own serum. Winsser and Makstenieks's paper (1949) led us to realize that this was unnecessary, as " accessory factor," or "activator" as they call it, can easily be supplied by fresh serum taken from a normal donor. It has not been our practice to inactivate the patient's serum, as we have found no difference between noninactivated serum and serum inactivated for half an hour at 56' C. Nor have we found the antibody titre of serum to fall during the day or two spent in the post. When received the serum is stored at about 4' C. Dilutions of serum we make up in saline, not in activator serum, for that would result in varying quantities of activator being present in the dilution tubes, and we have evidence that the amount of activator influences the result.
Activator.-The sera of many normal persons contain antibody in small amounts. Such sera are not suitable as sources of activator. When we are selecting a donor we first mix his fresh serum with nmouse peritoneal exudate rich in Toxoplasma, incubate, and then stain. Only if we find that few, if any, Toxoplasma are unstained do we use that person as a donor. Latterly we have developed a pool of suitable donors from members of laboratory staffs and patients with polycythaemia. The separated serum is bottled in 5-ml. amounts and kept at -20' C. until required. Thus stored we find that activator retains its potency unimpaired for at least three months.
Dye.-We use the saturated alcoholic solution of methylene blue described by Sabin and Feldman (1948) (Cathie and Dudgeon, 1949) With strongly positive sera subsequent tests, including dilutions up to 1:1,024, or higher, are made.
The same pipette is used throughout and is washed with saline between measurements of the different reagents.
The reason for one hour's incubation is that intracellular Toxoplasma, if there be any in the suspension. are liberated by disintegration of some of the tissue cells during the first half-hour. A further half-hour must be allowed to permit the antibody to act on them.
After the dye has been added the tubes are put in the refrigerator and each one kept there until we are ready to examine it. We much prefer to make the examination on the day the tests are set up, as the unstained Toxoplasma are then much clearer and less shrivelled than if left until the next day.
Reading the Test. We are now able to take time to determine the number of Toxoplasma in our suspension. We make a count in a Neubauer counting chamber of the stained extracellular Toxoplasma in the activator control tube. As they take longer to sediment than do red blood corpuscles, time must be allowed for this by leaving the chamber for 10 minutes in the refrigerator. The percentage of stained and unstained Toxoplasma in the various tubes is next determined. To do this we place two drops on a coverslip and place a slide on top. The slide is then turned over and examined under a 1/6 in. objective with the light cut down. Often there are marked variations in the thickness of the film due to irregularities in the slide or coverslip. We try to examine portions of even thickness. Thick portions tend to give an erroneously high count of stained Toxoplasma, probably because the unstained are less easily seen and because larger Toxoplasma which are less readily modified by antibody are more likely to be found there. In the control tube 12% of Toxoplasma were found unstained. Half of the remainder is 44%, to which is added 12%. The end titre will be the serum dilution corresponding to 56% of unstained Toxoplasma. By interpolation this is found to be a dilution of 1 :21. This was, however, for a suspension containing 3,750 stained Toxoplasma in the control tube. Our standard suspension is 30,000 (5,000 in the final mixture). We therefore multiply 1/21 by 5,000 and divide by 3,750, giving a corrected end titre of 1:16.
It should be noted that this is the final dilution of serum after activator and Toxoplasma suspension have been added. Sabin and Feldman (1948) record their results in terms of the original dilution of serum.
It would therefore be expected that our end titres would be four times as high, but they dilute their peritoneal exudate 1: 5. We use ours undiluted. If our contention that there is a direct relationship between the number of Toxoplasma and the amount of antibody necessary to modify them is correct, then our results and theirs should be substantially the same. We have some indication that this is so, for we freeze-dried a few specimens of serum and sent them to Dr. Feldman, who very kindly reconstituted and examined them for us (Table II) . When we expected them to reach him we reconstituted duplicate freeze-dried samples and examined them. As it turned out our examination was about three weeks before his. 
Interpretation
There should be no difficulty in interpretation in active or recently active congenital or acquired infections. Titres in these cases will be in the hundreds and often in the thousands. Where difficulty does arise is in assessing the significance of lower titres in the serum of persons who have choroido-retinitis or some other,clinical condition which may be due to infection with Toxoplasma several years previously. Some " normal " adults 4re found to have antibody by this test, although in most cases this is found only in low titres (Table  III) . It is possible that this may be due to nonspecific stimulation. To us it seems more probable that it is specific and due to infection which has not caused clinical manifestations. For a titre to be considered significant it must be shown that it is above that commonly found in persons of the patient's age. We have examined sera from chil- Somewhat similar results have been obtained by Westphal (1950) in Germany. Higher figures are given from Sweden by von Zeipel and Linder (1951) .
We realize that titres lower than those we are prepared to accept may be given by the sera of patients who have been infected with Toxoplasma in the distant past and are left only with the endresult of that infection. We realize, too, that, as shown' by Sabin and Feldman (1949) and Macdonald (1950) 
